THERMOCOOL® SF NAV BI-DIRECTIONAL CATHETER
Report
- Report Number
- 9673241-2013-00117
- Event Type
- Injury
- Date Received
- April 22, 2013
- Date of Event
- April 5, 2013
- Report Date
- April 5, 2013
- Manufacturer
- BIOSENSE WEBSTER, INC. (JUAREZ)
- Product Code
- LPB
- PMA / PMN Number
- P030031/S025
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TN, US
- Reporter Occupation
- OTHER
Narratives
CONCOMITANT MEDICAL PRODUCTS: CARTO 3 SYSTEM: MODEL #: M-4800-01, SERIAL #: (B)(4); STOCKERT 70 SYSTEM: MODEL #: M-5463-01, SERIAL #: (B)(4); COOL FLOW PUMP: MODEL #: M-5491-02, SERIAL #: (B)(4); LASSO CATHETER: MODEL #: D-1343-01-S, LOT #: 15802495L. (B)(4).
(B)(4). DURING AN ATRIAL FIBRILLATION (AFIB) PROCEDURE IT WAS REPORTED THERE WAS A HIGH IMPEDANCE ON THE STOCKERT DURING ABLATION TOWARDS THE END OF THE CASE. AFTER A COUPLE OF MINUTES THE PATIENT'S BLOOD PRESSURE DROPPED. EPINEPHRINE WAS GIVEN TO THE PATIENT IMMEDIATELY TO BRING THE BLOOD PRESSURE BACK. ULTRASOUND SCAN AND TRANSTHORACIC ULTRASOUND CONFIRMED PERFORATION ON THE LEFT ATRIUM. PERICARDIOCENTESIS WAS PERFORMED AND APPROXIMATELY 400 CC OF FLUID WAS REMOVED. THE PATIENT WAS STABILIZED AND UNDER OBSERVATION. ADDITIONAL INFORMATION PROVIDED STATED THE PHYSICIAN STATED THERE MAY HAVE BEEN A POUCH IN THE ROOF THAT MAY HAVE BEEN SUSCEPTIBLE TO TOO MUCH ABLATING WHICH MIGHT CONTRIBUTE TO THE CARDIAC PERFORATION/TAMPONADE EVENT. IT WAS UPDATED THE PATIENT WAS OBSERVED. ANOTHER TRANSTHORACIC ULTRASOUND PERFORMED AND NO MORE EFFUSION WAS FOUND. PATIENT WAS IN GOOD HEALTH AND WAS SENT HOME ON (B)(6). THE RETURNED DEVICE WAS VISUALLY INSPECTED UPON RECEIPT AND IT WAS FOUND IN NORMAL CONDITIONS. THE CATHETER WAS TESTED FOR ELECTRICAL PERFORMANCE, TEMPERATURE RESPONSE AND STOCKERT COMPATIBILITY AND IT WAS FOUND WITHIN SPECIFICATIONS. FURTHERMORE, AN IRRIGATION TEST WAS PERFORMED AND THE CATHETER PASSED, NO OCCLUSION WAS OBSERVED. COOL FLOW PUMP TEST WAS PERFORMED AND THE CATHETER PASSED SPECIFICATIONS. THE CATHETER WAS ALSO EVALUATED FOR EEPROM, CARTO 3, 4 KHZ AND CALIBRATION FUNCTIONALITY. THE CATHETER WAS RECOGNIZED BY CARTO 3 SYSTEM, NO ERROR MESSAGES WERE DISPLAYED AND THE CATHETER WAS PROPERLY VISUALIZED. EEPROM DATA DEMONSTRATES THE CATHETER WAS PROPERLY CALIBRATED DURING MANUFACTURING. FINALLY, A DEFLECTION TEST WAS PERFORMED AND THE CATHETER PASSED. THE DEVICE HISTORY RECORD (DHR) WAS REVIEWED AND NO ANOMALIES WERE FOUND RELATED TO THIS COMPLAINT. IN ADDITION, THE DHR REVIEW VERIFIES THAT THE DEVICE WAS MANUFACTURED IN ACCORDANCE WITH DOCUMENTED SPECIFICATION AND PROCEDURES. THE CATHETER PASSED ALL SPECIFICATIONS. THE ROOT CAUSE OF THE PERFORATION REMAINS UNKNOWN. THE IFU STATES THAT CAREFUL CATHETER MANIPULATION MUST BE PERFORMED IN ORDER TO AVOID CARDIAC DAMAGE, PERFORATION OR TAMPONADE.
DURING AN ATRIAL FIBRILLATION (AFIB) PROCEDURE, IT WAS REPORTED THERE WAS A HIGH IMPEDANCE ON THE STOCKERT DURING ABLATION TOWARDS THE END OF THE CASE. AFTER A COUPLE OF MINUTES THE PATIENT'S BLOOD PRESSURE DROPPED. EPINEPHRINE WAS GIVEN TO THE PATIENT IMMEDIATELY TO BRING THE BLOOD PRESSURE BACK. ULTRASOUND SCAN AND TRANSTHORACIC ULTRASOUND CONFIRMED PERFORATION ON THE LEFT ATRIUM. PERICARDIOCENTESIS WAS PERFORMED AND APPROXIMATELY 400 CC OF FLUID WAS REMOVED. THE PATIENT WAS STABILIZED AND UNDER OBSERVATION. ADDITIONAL INFORMATION PROVIDED STATED THE PHYSICIAN STATED THERE MAY HAVE BEEN A POUCH IN THE ROOF THAT MAY HAVE BEEN SUSCEPTIBLE TO TOO MUCH ABLATING WHICH MIGHT CONTRIBUTE TO THE CARDIAC PERFORATION/TAMPONADE EVENT. IT WAS UPDATED THE PATIENT WAS OBSERVED. ANOTHER TRANSTHORACIC ULTRASOUND PERFORMED AND NO MORE EFFUSION WAS FOUND. PATIENT WAS IN GOOD HEALTH AND WAS SENT HOME ON (B)(6) 2113.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 172545 | THERMOCOOL® SF NAV BI-DIRECTIONAL CATHETER | CARDIAC ABLATION PERCUTANEOUS CATHETER | LPB | BIOSENSE WEBSTER, INC. (JUAREZ) | D-1313-05-S | 15797557L |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 78 YR | Hospitalization| L| R |